The hypoparathyroidism treatment space has made a buzz in 2024 with a major drug approval, acquisitions, and big advances in ...

A Gastroenterologist at Ohio State Wexner Medical Center on Thursday refuted an inaccurate claim made by the Chief Minister ...

StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report published on Sunday morning. The firm issued a sell rating on the biopharmaceutical ...

The air pollutants are more than just a respiratory hazard; they also interfere with bone density and mineral composition ...

Dr R. Goswami, professor of endocrinology at AIIMS, says ‘sunshine exposure’ is best way to get Vitamin D, highlights ...

These diverse observations were interpreted in accordance with current knowledge of vitamin D and parathyroid hormone interrelations. The acquired excretory abnormality involving amino acid and ...

They produce parathyroid hormone (PTH), which helps maintain the balance of calcium essential for various bodily functions, like your nervous system and muscle function. When calcium levels drop, ...

Revuforj was approved by the FDA for adults and children with relapsed/refractory acute leukemia with a KMT2A translocation.

Nearly 300,000 bottles of the drug, named Cinacalcet, were recalled and given a Class II recall risk level by the FDA.

Interaction tests showed a significant association between sex and age with AKI status and fractures, but not CKD stage or osteoporosis. An AKI episode increases FGF-23 levels and parathyroid hormone ...

Calcimimetics suppress the secretion of parathyroid hormone by sensitizing the parathyroid calcium receptor to serum calcium. Cinacalcet (Sensipar ® /Mimpara ®, Amgen Inc., Thousand Oaks ...

Adults with hypoparathyroidism treated with TransCon PTH in the phase 3 PaTHway open-label trial extension demonstrated ...